Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN362167 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1) (pSer221) antibody
- Antibody type
- Polyclonal
- Antigen
- Peptide sequence around phosphorylation site of pSer221 (A-N-S (p) -F-V) derived from Human MEK1. Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates.
- Description
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific phosphopeptide. The antibody against non-phosphopeptide was removedby chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- pSer221
- Isotype
- IgG
- Vial size
- 50 μL
- Concentration
- 1 mg/mL
- Storage
- Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
Submitted references Magnesium deprivation inhibits a MEK-ERK cascade and cell proliferation in renal epithelial Madin-Darby canine kidney cells.
Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia.
Phosphorylation of threonine 290 in the activation loop of Tpl2/Cot is necessary but not sufficient for kinase activity.
Negative regulation of MAPKK by phosphorylation of a conserved serine residue equivalent to Ser212 of MEK1.
MAD2-induced sensitization to vincristine is associated with mitotic arrest and Raf/Bcl-2 phosphorylation in nasopharyngeal carcinoma cells.
Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth.
Ikari A, Atomi K, Kinjo K, Sasaki Y, Sugatani J
Life sciences 2010 May 8;86(19-20):766-73
Life sciences 2010 May 8;86(19-20):766-73
Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia.
Zebisch A, Staber PB, Delavar A, Bodner C, Hiden K, Fischereder K, Janakiraman M, Linkesch W, Auner HW, Emberger W, Windpassinger C, Schimek MG, Hoefler G, Troppmair J, Sill H
Cancer research 2006 Apr 1;66(7):3401-8
Cancer research 2006 Apr 1;66(7):3401-8
Phosphorylation of threonine 290 in the activation loop of Tpl2/Cot is necessary but not sufficient for kinase activity.
Luciano BS, Hsu S, Channavajhala PL, Lin LL, Cuozzo JW
The Journal of biological chemistry 2004 Dec 10;279(50):52117-23
The Journal of biological chemistry 2004 Dec 10;279(50):52117-23
Negative regulation of MAPKK by phosphorylation of a conserved serine residue equivalent to Ser212 of MEK1.
Gopalbhai K, Jansen G, Beauregard G, Whiteway M, Dumas F, Wu C, Meloche S
The Journal of biological chemistry 2003 Mar 7;278(10):8118-25
The Journal of biological chemistry 2003 Mar 7;278(10):8118-25
MAD2-induced sensitization to vincristine is associated with mitotic arrest and Raf/Bcl-2 phosphorylation in nasopharyngeal carcinoma cells.
Wang X, Jin DY, Wong HL, Feng H, Wong YC, Tsao SW
Oncogene 2003 Jan 9;22(1):109-16
Oncogene 2003 Jan 9;22(1):109-16
Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth.
Ling MT, Wang X, Ouyang XS, Lee TK, Fan TY, Xu K, Tsao SW, Wong YC
Oncogene 2002 Dec 5;21(55):8498-505
Oncogene 2002 Dec 5;21(55):8498-505
No comments: Submit comment
No validations: Submit validation data